Senores Pharmaceuticals
add_icon

Senores Pharmaceuticals

810.30
-4.80
(-0.59%)
Market Cap
3,731.72 Cr
PE Ratio
36.50
Volume
76,485.00
Day High - Low
818.90 - 805.30
52W High-Low
876.50 - 440.30
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
3,731.72 Cr
EPS
16.12
PE Ratio
36.50
PB Ratio
4.61
Book Value
155.06
EBITDA
109.00
Dividend Yield
0.00 %
Industry
Healthcare
Return on Equity
7.18
Debt to Equity
0.58
Analyst Rating and Forecast
- By Refinitiv from4 analysts
BUY
Analysts have suggested that investors can buy this stock
Buy
Buy+100.00 %
+100.00 %
Hold
Hold0.0 %
0.0 %
Sell
Sell0.0 %
0.0 %
Forecast For
Actual

Company News

View All News
Caret
neutral
Espee Therapeutics LLP pledges 4,00,000 equity shares of Senores Pharmaceuticals to Bajaj Finance Limited as collateral for loan taken by Renosen Pharmaceuticals Private Limited on February 13, 2026.
neutral
Espee Therapeutics LLP pledges 4,00,000 equity shares of Senores Pharmaceuticals to Bajaj Finance Limited as collateral for loan taken by Renosen Pharmaceuticals Private Limited.
positive
Senores Pharmaceuticals' EGM on January 31, 2026 approved issuance of 11,70,000 convertible equity warrants to promoter group via preferential allotment with 96.45% votes in favor.
View more
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,724.40
#1 4,13,741.32
37.53
#1 54,729.00
9.71
#1 10,980
16.07
58.16
6,291.00
1,67,006.28
67.40
9,712.00
18.67
2,191
-1.02
53.89
4,241.70
1,43,558.40
62.90
11,539.40
6.99
1,911
26.24
66.58
1,341.10
1,08,330.28
23.68
28,409.50
7.12
5,291
-57.18
43.41
1,280.40
1,06,866.07
19.34
33,741.20
16.73
5,725
-15.28
60.10
2,219.40
1,01,381.93
21.81
22,909.50
13.74
3,306
#1 37.44
57.52
900.75
90,636.53
#1 18.06
23,511.00
18.55
4,615
-0.32
49.52
2,024.30
83,564.13
46.65
12,744.20
#1 20.90
2,007
7.65
38.95
1,158.80
67,303.29
19.60
32,345.60
9.43
3,484
7.59
47.48
5,392.00
64,469.45
26.53
13,458.30
3.70
2,216
1.90
37.57

Automatic Screeners on ScanX

Growth Rate
Revenue Growth
92.13 %
Net Income Growth
78.29 %
Cash Flow Change
-78.68 %
ROE
-49.15 %
ROCE
1.63 %
EBITDA Margin (Avg.)
27.75 %

Quarterly Financial Results

Quarterly Financials
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Revenue
80
104
80
100
108
117
134
159
169
Expenses
64
80
59
77
77
95
104
112
121
EBITDA
16
24
21
23
31
22
30
47
48
Operating Profit %
19 %
22 %
26 %
21 %
25 %
10 %
20 %
27 %
27 %
Depreciation
3
4
4
4
4
5
6
8
8
Interest
3
3
5
5
6
5
5
6
5
Profit Before Tax
10
18
14
16
21
21
27
41
45
Tax
3
3
3
3
4
3
5
11
11
Net Profit
7
14
11
13
16
18
21
30
34
EPS in ₹
4.01
8.03
3.39
3.92
5.04
3.81
4.60
6.54
7.29

Balance Sheet

Balance Sheet
2022
2023
2024
2025
Total Assets
59
131
622
1,227
Fixed Assets
7
27
235
301
Current Assets
27
51
251
722
Capital Work in Progress
8
35
97
173
Investments
15
17
0
0
Other Assets
29
53
289
754
Total Liabilities
59
131
622
1,227
Current Liabilities
10
52
248
241
Non Current Liabilities
13
34
143
174
Total Equity
37
46
232
812
Reserve & Surplus
28
36
174
740
Share Capital
9
10
31
46

Cash Flow

Cash Flow
2022
2023
2024
2025
Net Cash Flow
2
-3
8
98
Investing Activities
-24
-48
-54
-430
Operating Activities
-10
-1
-26
-46
Financing Activities
37
46
87
573

Share Holding

% Holding
Jul 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Promoter
66.66 %
45.76 %
45.76 %
45.77 %
45.78 %
45.80 %
45.80 %
FIIs
0.00 %
5.51 %
4.25 %
4.17 %
3.67 %
4.28 %
3.35 %
DIIs
0.00 %
18.61 %
11.78 %
9.65 %
9.51 %
8.61 %
9.31 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
0.00 %
27.88 %
28.71 %
31.43 %
31.44 %
31.09 %
31.94 %
Others
33.34 %
2.23 %
9.49 %
8.97 %
9.60 %
10.22 %
9.59 %
No of Share Holders
177
43,707
43,707
37,653
36,389
34,917
34,401

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
23 Jan 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
23 Jan 2025 530.80 498.50
15 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
15 May 2025 483.75 541.05
23 Jul 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
23 Jul 2025 617.55 616.35
18 Sept 2025 ANNUAL GENERAL MEETING Annual General Meeting
NA
18 Sept 2025 717.85 689.25
06 Nov 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
06 Nov 2025 783.35 766.75
20 Jan 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
20 Jan 2026 812.35 806.55
31 Jan 2026 EXTRAORDINARY GENERAL MEETING Extraordinary General Meeting
NA
31 Jan 2026 845.15 787.35

Announcements

Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.5 days ago
Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.5 days ago
Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.5 days ago
Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.5 days ago
Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 20159 days ago
Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Feb 04, 2026
Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportJan 31, 2026
Shareholder Meeting / Postal Ballot-Outcome of EGMJan 31, 2026
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptJan 27, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationJan 21, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeJan 20, 2026
Submission Of Statement Of Deviation Or Variation In Utilisation Of Funds Of Public Issue For Quarter Ended On December 31 2025Jan 20, 2026
Submission Of Statement Of Deviation Or Variation In Utilisation Of Funds Of Public Issue For Quarter Ended On December 31 2025Jan 20, 2026
Announcement under Regulation 30 (LODR)-Monitoring Agency ReportJan 20, 2026
Announcement under Regulation 30 (LODR)-Investor PresentationJan 20, 2026
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJan 20, 2026
Corrigendum To The Media Release Submitted With The Outcome Of The Board Meeting Dated January 20 2026Jan 20, 2026
Results For Quarter And Nine Months Ended December 31 2025Jan 20, 2026
Board Meeting Outcome for Outcome Of Board MeetingJan 20, 2026
Announcement under Regulation 30 (LODR)-Updates on AcquisitionJan 16, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJan 15, 2026
Board Meeting Intimation for Considering And Approving The Un-Audited Standalone And Consolidated Financial Results Of The Company For The Quarter And Nine Months Ended December 31 2025 And To Transact Other Business MattersJan 13, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 12, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationJan 12, 2026
Notice Of Extra-Ordinary General Meeting Of The Company Scheduled To Be Held On Saturday January 31 2026Jan 09, 2026
Board Meeting Outcome for Outcome Of Board Meeting Held On January 07 2026Jan 07, 2026
Board Meeting Intimation for Considering And Evaluating Proposals For Raising Funds By Way Of Issue Of Convertible Warrants On Preferential Basis To The Promotors/Promoter Group Including Determination Of Issue PriceJan 03, 2026
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Jan 01, 2026
Revised Intimation Under Regulation 30 Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015Dec 30, 2025
Intimation Under Regulation 30 Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015Dec 29, 2025
Transcript Of Business Update CallDec 22, 2025
Intimation Under Regulation 30 Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015Dec 20, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Dec 18, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeDec 16, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationDec 15, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationDec 15, 2025
Announcement under Regulation 30 (LODR)-AcquisitionDec 15, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseDec 11, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationDec 05, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseDec 05, 2025
Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.Dec 05, 2025
Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.Dec 05, 2025
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptNov 13, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 07, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeNov 06, 2025
Announcement under Regulation 30 (LODR)-Monitoring Agency ReportNov 06, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementNov 06, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationNov 06, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseNov 06, 2025
Results For Quarter And Half Year Ended September 30 2025Nov 06, 2025

Technical Indicators

RSI(14)
Neutral
50.49
ATR(14)
Less Volatile
28.53
STOCH(9,6)
Neutral
38.98
STOCH RSI(14)
Neutral
66.26
MACD(12,26)
Bullish
0.27
ADX(14)
Weak Trend
11.75
UO(9)
Bearish
42.04
ROC(12)
Downtrend And Accelerating
-1.13
WillR(14)
Neutral
-50.91